OPN-5667

N/A

Report date: 2026/02/11 20:01:36
NME

Base Information

Drug NameOPN-5667
Drug Alias NameOPN-5667OPN5667
ClassificationSmall molecules
Mechanisms of ActionHistone acetyltransferase p300 degraderscAMP-response element binding protein degradersDNA-binding protein Ikaros degraders +[4] 
TargetsHistone acetyltransferase p300cAMP-response element binding proteinDNA-binding protein Ikaros +[4] 
Therapy Area/IndicationsMultiple MyelomaLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOpna Bio AG
China Registration ClassN/A

Develop Information

Active CompaniesOpna Bio AG
Inactive CompaniesN/A
Active IndicationsMultiple MyelomaLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A